SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Bristol-Myers Squibb Company ’s Second Quarter Highlighted by the Planned Strategic Acquisition of Amylin Pharmaceuticals, Inc. and Important Clinical Data in Immuno-Oncology